Xvivo Perfusion AB (publ) (STO:XVIVO)
Sweden · Delayed Price · Currency is SEK 235.20
-0.40 (-0.17%)
Jul 24, 2026, 5:29 PM CET
Xvivo Perfusion AB Market Cap
Xvivo Perfusion AB has a market cap or net worth of 7.41 billion as of July 24, 2026. Its market cap has increased by 7.99% in one year.
Market Cap
7.41B
Enterprise Value
7.23B
Revenue
895.23M
Ranking
n/a
PE Ratio
83.65
Stock Price
235.20
ChartMarket Cap Chart
Since October 8, 2012, Xvivo Perfusion AB's market cap has increased from 371.69M to 7.41B, an increase of 1,893.23%. That is a compound annual growth rate of 24.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 7.41B | 26.05% |
| Dec 30, 2025 | 5.88B | -61.84% |
| Dec 30, 2024 | 15.40B | 48.41% |
| Dec 29, 2023 | 10.38B | 90.12% |
| Dec 30, 2022 | 5.46B | -33.55% |
| Dec 30, 2021 | 8.22B | -8.90% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Getinge AB | 62.40B |
| Sectra AB | 50.32B |
| Elekta AB | 17.46B |
| Nolato AB | 12.73B |
| Vitrolife AB | 11.59B |
| MedCap AB | 8.22B |
| CellaVision AB | 3.32B |
| C-Rad AB | 1.23B |